Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Elizabeth R.
Elizabeth R. Dyor, Washington, DC US
| Patent application number | Description | Published |
|---|---|---|
| 20100332353 | Financial Management System - A financial management system includes a client terminal having a financial management application and a graphical user interface. The graphical user interface is configured to display transaction data, enable user modification of the transaction data, and transmit modified transaction data to the financial management application. The financial management system additionally includes a commercial web server capable of conducting online financial transactions. The financial management application receives transaction data regarding an online financial transaction upon completion of the financial transaction. | 12-30-2010 |
Elizabeth R. Jurrus, Kennewick, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20090271406 | SEQUENTIAL PATTERN DATA MINING AND VISUALIZATION - One or more processors ( | 10-29-2009 |
Elizabeth R. Kupp, Centre Hall, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090108507 | Method for manufacture of transparent ceramics - The disclosed invention relates to a method of manufacture of transparent ceramics such as yttrium aluminum garnet by tape casting. The method entails forming a mixture of ceramic oxide, dispersant and organic solvent, milling the mixture to produce a first slurry, mixing the first slurry with an organic binder and a plasticizer to form a treated slurry, milling the treated slurry to produce milled slurry, tape casting the milled slurry to produce cast tape, drying the cast tape to produce dried tape, stacking portions of dried tape to form an assembly, compressing the assembly to produce a preform, heating the preform to produce a green preform, and sintering the green preform to produce transparent yttrium aluminum garnet. The method may be used to produce a unitary ceramic product having differing transparent sections as well as transparent ceramic product having a dopant gradient across a portion of the thickness of the product. | 04-30-2009 |
Elizabeth R. Mccanlies, Aptos, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090013037 | System Providing Methods for Dynamic Customization and Personalization of User Interface - A system providing methods for dynamically generating personalized content is described. Specific items of content which may be personalized or customized are identified. Subdirectories are created for each value of such personalized content. Files specific to each value of personalized content are created and placed in these subdirectories. When a user requests a particular web page or item of content, a token is retrieved identifying the personalized content to be generated for that particular user. Personalized content is then dynamically generated by construction of a path to at least one subdirectory containing personalized content. The path to such subdirectory containing personalized content is dynamically constructed based upon the token identifying such personalized content. | 01-08-2009 |
Elizabeth R. Proos, Westford, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090142386 | CONTROL OF DRUG RELEASE BY TRANSIENT MODIFICATION OF LOCAL MICROENVIRONMENTS - Methods, formulations, and devices are provided for enhancing drug delivery from a medical device. The method is provided for increasing the rate or quantity of a drug formulation released from an implantable drug delivery device, which method comprises the step of providing a release-modifying agent within or proximate to the implantable drug delivery device, in a manner effective to inhibit gelation, aggregation, or precipitation of the drug formulation being released from the device. The drug formulation and the release-modifying agent may be stored together in at least one reservoir in the implantable drug deliver device. Alternatively, the release-modifying agent may be stored in one or more reservoirs separate from the drug formulation. | 06-04-2009 |